NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

Longfellow95, Thanks for your insight and link. I own both BMY (BMS) and MRK. Been mulling this over for a while as I've been too busy to post much of any consequence. To paraphrase Sir Winston in regards to Direct-L-The FDA will do the right thing after exhausting the alternatives. I doubt if this is the intent or reason for the delay. But considering the autologous manufacturing complexity of Direct in comparison to say a relatively simple protein CI I would want to understand the efficacy of the easier to produce therapies before addressing the more complex to produce therapies. From this perspective, and as this space is evolving, the delay has likely helped the FDA in some respects. Would welcome your thoughts and I might ping DoingMyBest too for their perspective. TIA